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Background: Carbon monoxide (CO) is a cytoprotective and 
homeostatic molecule with important signaling capabilities in 
physiological and pathophysiological situations. CO protects 
cells/tissues from damage by free radicals or oxidative 
stress. NAD(P)H:quinone oxidoreductase (NQO1) is a highly 
inducible enzyme that is regulated by the Kelch-like ECH-as-
sociated protein 1 (Keap1)/nuclear factor erythroid 2-re-
lated factor 2 (Nrf2)/antioxidant response element (ARE) 
pathway, which is central to efficient detoxification of re-
active metabolites and reactive oxygen species (ROS). 
Methods: We generated NQO1 promoter construct. HepG2 
cells were treated with CO Releasing Molecules-2 (CORM-2) 
or CO gas and the gene expressions were measured by 
RT-PCR, immunoblot, and luciferase assays. Results: CO in-
duced expression of NQO1 in human hepatocarcinoma cell 
lines by activation of Nrf2. Exposure of HepG2 cells to CO 
resulted in significant induction of NQO1 in dose- and 
time-dependent manners. Analysis of the NQO1 promoter 
indicated that an antioxidant responsible element (ARE)- 
containing region was critical for the CO-induced Nrf2-de-
pendent increase of NQO1 gene expression in HepG2 cells. 
Conclusion: Our results suggest that CO-induced Nrf2 in-
creases the expression of NQO1 which is well known to de-
toxify reactive metabolites and ROS.
[Immune Network 2011;11(6):376-382]
INTRODUCTION
Carbon monoxide (CO) is a reaction product of the cytopro-
tective  heme  oxygenase  (HO-1) (1).  Endogenous  HO-1  has 
the potential to generate CO, bilirubin and iron (Fe
＋＋) at the 
time of heme breakdown. CO has beneficial effects on many 
patho-physiological  conditions,  which  mimics  the  role  of 
HO-1  (2,3).  Recently,  CO  has  emerged  as  a  potential  ther-
apeutic agent for the treatment of various cardiovascular dis-
orders (2-4). There is an abundance of preclinical evidence 
in large and small animals showing the beneficial effects of 
CO, administered as a gas or as a CO Releasing Molecules 
(CORM), on cardiovascular disease, sepsis and shock, cancer, 
acute and chronic rejection of a transplanted organ, and acute 
lung,  kidney  and  liver  injuries  (5). 
    NAD(P)H:quinone oxidoreductase (NQO1), a cytosolic fla-
voprotein that catalyzes quinine detoxification, is induced in 
response  to  various  agents  at  the  transcriptional  level.  The 
N Q O 1  e n z y m e  i s  i m p l i c a t e d  i n  p r o t e c t i o n  a g a i n s t  o x i d a t i v e  
stress (6,7) and carcinogenesis, including stabilization of the 
p53 tumor suppressor (8-10). NQO1-deficient mice show re-
duced  p53  induction  and  apoptosis,  increased  susceptibility 
to chemically induced tumors (11) and impaired NF-κB func-
tion (12). The NQO1 gene promoter region contains several 
essential cis-elements including xenobiotic response element 
(XRE) and antioxidant response element (ARE) (13). Induc-
tion of NQO1 expression by various stimuli has been reported 
to  be regulated by ARE  (14-16), which contains several re-
ceptors for several nuclear transcription factors such as Nrf2. 
    The transcription factor Nrf2 (nuclear factor erythroid 2-re-
lated factor 2) is a key oxidative stress response modifier that 
induces  transcription  of  a  variety  of  genes  through  binding 
to the antioxidant response element (ARE) in target gene pro-
moters (17-19). Nrf2-dependent activation of ARE-driven gene 
promoters is generally understood to lead to induction of cy-
toprotective proteins, which enable cells to combat oxidative 
insult  (18,19). CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
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    In unstressed cells, Nrf2 activity is thought to be repressed 
by Keap1 (Kelch-like ECH-associated protein 1) (20,21), a cy-
toskeleton-associated protein. Ubiquitin-mediated degradation 
of  Nrf2  is  induced  by  its  binding  to  Keap1.  In  one  model 
for the activation of Nrf2 in stressed cells, electrophile- or re-
active oxygen species-induced release of Nrf2 is proposed to 
involve covalent modifications of Keap1 and/or Nrf2 in the 
cytoplasm. In addition, microarray results suggest that more 
than  200  gene  products  including  an  antioxidative  enzyme 
NQO1  are  under  the  transcriptional  control  for  Nrf2  (17).
    In this study, we demonstrate that CO induces NQO1 gene 
expression  through  the  Nrf2-dependent  pathway. 
MATERIALS AND METHODS
Cell culture and reagents
The  human  hepatocarcinoma  cell  lines  (HepG2)  were  cul-
t u r e d  i n  D M E M  ( G i b c o ,  N Y ) .  A l l  m e d i a  w a s  s u p p l e m e n t e d 
w i t h  1 0 %  f e t a l  b o v i n e  s e r u m  a n d  a  1 0 0  u n i t s / m l  p e n -
icillin-streptomycin mixture (Gibco, NY). Cell lines were in-
cubated at 37
oC with 100% humidity in 5% CO2 and passaged 
using  standard  cell  culture  techniques.  Ticharbonyl  di-
chlororuthenium (II) dimer (CORM-2) was from Sigma-Aldrich 
(St.  Louis,  MO). 
Plasmid constructs and siRNA
The sequence of the human NQO1 genomic locus at 16q22.1 
(GenBank accession number NM_000016.9) was used to en-
gineer PCR cloning primers. A 618 base pair (bp) genomic 
fragment containing the 5'-flanking region of the NQO1 gene 
was  isolated  by  PCR  amplification  from  human  genomic 
DNA. Construct pGL3/NQO1p-501 contains the −501 bp pro-
moter region of the human NQO1 gene up to nucleotide＋
117 bp (i.e., downstream from the NQO1 mRNA capsite) in-
serted into the SacI and XhoI sites of the pGL3 basic vector 
(Promega). Oligonucleotides for construct pGL3/NOQ1p-ARE 
were  synthesized  at  Bioneer  Corporation.  The  oligonucleo-
tides were ligated into the SacI and XhoI sites of the pGL3 
basic vector. Nucleotide sequences of the primers were as 
follows:  pGL3/NQO1p-501:  5'-GAGCTCGTGCAGAATCTG-
AATCTTGCAAAG-3' (sense) and 5'- CTCGAGGCTCTGGTG-
CAGTCCGGGGCGCT-3'  (antisense).  pGL3/NQO1p-ARE:  5'- 
CCTCAGCCTTCCAAATCCGCAGTCACAGTGACTCAGCAGAA
TCC-3'  (sense),  TCGAGGATTCTGCTGAGTCACTGTGACTG-
CGGATTTGGAAGGCTGAGGAGCT-3' (antisense). The mam-
malian expression plasmid pcDNA3 bearing human Nrf2 was 
obtained  from  Addgene  (Cambridge,  MA). 
    Small interfering RNAs (siRNAs) against human Nrf2 (Nrf2- 
siRNA) (sc37030), human PERK (PERK-siRNA) (sc-36213) and 
control siRNA (scRNA) (sc-37007) were purchased from Santa 
Cruz  Biotechnology  (Santa  Cruz,  CA).
Transient transfection and Luciferase Reporter assay 
HepG2 cells were plated in 24-well flat bottom plates on a 
day prior to transfection. Cells were then co-transfected with 
pGL3/NQO1p-501-luciferase reporter construct, pcDNA3-myc- 
Nrf2 and pRL-SV40 Renilla luciferase construct using Lipofec-
tamine reagent (Invitrogen, CA). Forty eight hours after trans-
fection, cells were lysed, and both firefly and Renilla lucifer-
ase activities were measured with Dual-Luciferase reporter as-
say system (Promega, WI), according to the manufacturer’s 
instructions.  The  luciferase  activities  were  measured  on  a 
SpectraMax L (M. Devices). Each experiment was carried out 
a t  l e a s t  3  t i m e s  w i t h  t r i p l i c a t e  s a m p l e s .  
RT-PCR
HepG2 cells were treated with the indicated concentration of 
CORM-2. At the indicated time after CORM-2 treatment, total 
RNA was prepared using Trizol reagent (Invitrogen, CA). Two 
microgram of total RNA was used to synthesize the first-strand 
cDNA by using oligo-dT primers (QIAGEN, CA) and M-MLV 
reverse transcriptase (Promega, WI) according to the manu-
facturer’s instructions. The synthesized cDNA was subjected to 
the PCR-based amplification. Oligonucleotide primer sets used 
were as follows: NQO1, 5'-GTATCCTGCCGAGTCTGTT-3' (sense) 
and 5'-GATCCCTTGCAGAGAGTACA-3' (antisense); HO-1, 5'- 
GGAACTTTCAGAAGGGCCAG-3' (sense) and 5'-GTCCTTGG-
TGTCATGGGTCA-3'  (antisense);  GAPDH,  5'-CCACCCATGG-
CAAATTCCATGGCA-3' (sense) and 5'-TCTAGACGGCAGGTC-
AGGTCCACC-3' (antisense). The expression of GAPDH was 
measured as an internal control. The PCR products were sub-
jected to agarose gel electorphoresis and visualized by ethi-
dium  bromide  staining. 
Immunoblot
For immunoblot, cells were lysed in a lysis buffer containing 
2 5  m M  T r i s - H C l ,  p H  7 . 5 ,  1 3 7  m M  N a C l ,  2 . 7  m M  K C l ,  1 %  
Triton X-100, and Halt
TM Protease and Phosphatase inhibitor 
cocktail  (Thermo  Scientific,  IL),  and  spun  to  separate  in-
soluble debris from the clear lysates. Equal amounts of cell 
lysates  were  separated  by  SDS-PAGE  and  transferred  onto 
Immobilon-P membranes (Millipore, Bedford, MA). The trans-CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
Hyo Jeong Kim, et al.
378 IMMUNE NETWORK http://www.ksimm.or.kr Volume 11 Number 6 December 2011
Figure 1. Dose-dependent NQO1 mRNA induction by exogenous CO. 
(A, B) HepG2 cells were treated with various concentrations of 
CORM-2 as exogenous CO donor or Rucl2 as control for 6 h and 
the cells were harvested for semi-quantitative RT-PCR. The mRNA 
expression of NQO1 was determined by semi-quantitative RT-PCR. 
GAPDH was used as internal controls.
Figure 2. Time dependent NQO1 mRNA induction by exogenous CO. 
(A, B) HepG2 cells were treated with 50 uM CORM-2 or 250 ppm 
CO gas for indicated time points and analyzed. The mRNA expression 
of NQO1 was determined by semi-quantitative RT-PCR as described 
under Material and methods. GAPDH was used as internal controls. 
Figure 3. Effects of exogenous CO on the NQO1 and HO-1 protein 
induction. HepG2 cells were treated with various concentrations of 
CORM-2 as exogenous CO donor for 6 h and the cell lysates were 
used for immunoblot with antibody against NQO1, HO-1, and β- 
actin. 
ferred  membranes  were  incubated  with  anti-NQO1  (Cell 
Signaling, DE), polyclonal anti-HO-1 (Enzo Life Sciences, NY), 
anti-actin (Santa Cruz Biotechnology, CA) antibody. Immuno-
reactivity was detected using the ECL detection system (GE 
Healthcare  Bio-Sciences  Corp.  NJ).
RESULTS
Exogenous CO induces NQO1 gene expression in 
HepG2 cells
CO, a reaction product of HO-1 activity, has been shown to 
have  potent  anti-inflammatory,  anti-proliferative,  and  an-
ti-apoptotic effects. In our previous study, we revealed that 
CO induces Nrf2 activation and HO-1 expression in the liver 
cells (22). Furthermore, activated Nrf2 might induce various 
proteins which play a role of cytoprotection. Because NQO1 
as one of the most cytoprotective molecules which is induced 
by  Nrf2 in  various  stress  conditions,  we  examined whether 
CO could increase NQO1 gene expression. As shown in Fig. 
1 A ,  N Q O 1  e x p r e s s i o n  w a s  i n c r e a s e d  b y  C O  i n  a  d o s e - d e -
pendent  manner  up  to  50μM  of  CORM-2.  To  confirm  the 
effect  of  metal  carrier  of  CORM-2,  cells  were  treated  with 
RuCl2 in a dose dependent manner. However, treatment of 
cells with equivalent molar concentrations of ruthenium chlor-
ide  (RuCl2)  did  not  induce  NQO1  expression  (Fig.  1B).  As 
shown in Fig. 2A, we also found that NQO1 expression was 
increased  in  a  time-dependent  manner.  Compared  with 
un-stimulated cells, an increase in NQO1 expression was ob-
served in cells exposed to CO for 6 h. We also found that 
NQO1 was induced by CO gas at 6 h (Fig. 2B). NQO1 protein 
expression, as well as NQO1 mRNA expression, was also in-
c r e a s e d  b y  C O R M - 2  i n  a  d o s e  d e p e n d e n t  m a n n e r  ( F i g .  3 ) . 
We report for the first time that exogenous CO induces NQO1 
expression  in  HepG2  cells. 
CO specifically induces NQO1 expression at the 
transcriptional level in HepG2 cells
Our previous studies showed that CO induces Nrf2 activation 
(22). Moreover, it has been reported that the importance of 
transcription factor Nrf2 in regulating ARE-dependent the tran-
scription of ARE-dependent NQO1 gene (23). We confirmed 
that  NQO1  expression  was  incre a s e d  b y  C O  a t  R N A  l e v e l s  
in  a  dose-dependent  manner  (Fig.  1  and  2).  To  confirm 
whether the expression of NQO1 mRNA induced by CORM-2 CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
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Figure 4. Effects of CORM-2 on the NQO1 promoter activity. HepG2 
cells were transfected with hNQO1p-501 containing the NQO1 
promoter (-501 to +117). After 24 h cells were treated with various 
concentrations of CORM-2. At 6 h post-treatment, the level of firefly 
luciferase activity was normalized to the Renilla luciferase activity. 
The relative luciferase activities are presented as a fold increase over 
no-treated cells. Each bar represents the mean±S.D. of three 
independent experiments (**p<0.01).
Figure 5. Effects of CORM-2 on Nrf2-mediated NQO1 promoter 
activity. HepG2 cells were co-transfected with pGL3/NQO1p-ARE and 
pcDNA3-Nrf2. After 24 h, cells were treated with 30 uM CORM-2 
and at 6 h post-treatment, luciferase activity was determined. The 
levels of firefly luciferase activity were normalized to the Renilla 
luciferase activity. The relative luciferase activities are presented as a 
fold increase over no-treated cells. Each bar represents the mean±S.D.
of three independent experiments (*p<0.05, ***p<0.001).
was due to transcriptional regulation,  we performed a pro-
moter activity assay on the NQO1 gene. First, we constructed 
the NQO1 promoter-luc plasmid (pGL3/NQO1p-501) by sub-
cloning  NQO1  promoter  region  into  the  pGL3  basic  vector 
for luciferase assay. After transfecting the indicated promoter 
constructs, cells were treated with CORM-2 for 6 h and luci-
ferase  activity  was  measured.  As  expected,  treatment  of 
CORM with pGL3/NQO1p-501 transfected cells resulted in a 
1.4 fold increase in NQO1 promoter activity when compared 
to pGL3/NQO1p-501 transfected cells (Fig. 4). These results 
indicate that CORM-2 also induces NQO1 promoter activity at 
the  transcriptional  level. 
Nrf2 and anti-oxidant responsive element are indis-
pensable for CO-mediated NQO1 expression
Nrf2 is a major transcription factor involved in cellular pro-
tection  against  oxidative  stress  through  ARE-mediated  in-
duction  of  several  phase  II  detoxifying  and  antioxidant  en-
zymes (24). It is known that Nrf2 regulates the antioxidant 
response element-mediated expression of NQO1 gene (25). 
To further evaluate the involvement of Nrf2 in CO-induced 
NQO1 expression, we constructed the plasmid containing an-
tioxidant  response  element  (pGL3/NQO1p-ARE)  within  the 
NQO1 promoter that might be involved in Nrf2-mediated in-
duction of the gene. Co-transfection studies were performed 
using Nrf2 expression plasmids and the pGL3/NQO1p-ARE lu-
ciferase promoter construct. As shown in Fig. 5, Nrf2-overex-
pression  increased  pGL3/NQO1p-ARE  promoter  activity  by 
∼5-fold  compared  with  pcDNA3  mock  vector  transfected 
cells. In addition, transfection of Nrf2 followed by CO treat-
ment  resulted  in  ∼1 . 4  f o l d  i n c r e a s e  i n  t h e  i n d u c t i o n  o f  
pGL3/NQO1p-ARE promoter activity. Based on these results, 
we suggest that Nrf2-mediated ARE activation is involved in 
CORM-2-induced  NQO1  gene  expression. 
Endogenous CO generated by CoPP and curcumin 
through HO-1 induces NQO1 expression in HepG2 
cells
Cobalt  protoporphyrin  (CoPP)  is  a  well-known  inducer  of 
HO-1 in many cell types. Curcumin also activates Nrf-2/HO-1 
pathway  (26).  Because  endogenous  HO-1  has  the  potential 
to generate CO, we wanted to know whether CoPP or curcu-
min also induce NQO1 expression through CO generated by 
HO-1. After treatment with CoPP or curcumin, we analyzed 
HO-1  expression  by  semi-quantitative  RT-PCR  at  different 
times. HO-1 expression was induced by CoPP or curcumin 
i n  a  t i m e - d e p e n d e n t  m a n n e r  ( F i g .  6 ) .  I n  a  s i m i l a r  f a s h i o n ,  
CoPP or curcumin also caused a significant increase in NQO1 
expression (Fig. 6). Collectively, these data support that ex-
pression of NQO1 is induced by CoPP or curcumin via HO-1 CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
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Figure 6. Effects of CoPP and curcumin on NQO1 expression. (A, B) 
HepG2 cells were treated with 10μM CoPP and 10μM curcumin 
for the indicated time period. Total RNA were extracted and 
expression of NQO1 and GAPDH mRNA was detected by semi- 
quantitative RT-PCR. 
Figure 7. Effects of silencing of Nrf2 on CO-induced NQO1 promoter 
activity HepG2 cells were transfected with pGL3/NQO1p-501 
containing the NQO1 promoter (-501 to +117), Nrf2 specific 
(siNRf2), and PERK specific (siPERK) or scrambled siRNA (scRNA). 
After 24 h cells were treated with various concentrations of CORM-2. 
At 6 h post-treatment, the level of firefly luciferase activity was 
normalized to the Renilla luciferase activity. The relative luciferase 
activities are presented as a fold increase over no-treated cells. Each 
bar represents the mean±S.D. of three independent experiments 
(*p<0.05, **p<0.01).
induction.
Nrf2 is responsible for CO-inducible NQO1 promoter 
activity
As shown in Fig. 4, CORM-2 treatment of HepG2 cells was 
able to significantly stimulate the NQO1 promoter at 6 h after 
the incubation. To confirm the involvement of Nrf2 for CO- 
induced  NQO1  promoter  activity,  we  inhibited  Nrf2  ex-
pression by siRNA against Nrf2. Down-regulation of Nrf2 by 
siRNA  abrogated  the  CO-induced  NQO1  promoter  activity 
(Fig. 7). These data indicate that the NQO1 promoter activity 
is under regulation of CO and Nrf2 in HepG2 cells. In addi-
tion,  our  previous  result  showed  that  CO  up-regulates 
Nrf2-dependent  HO-1  expression  via  PERK  activation  (27). 
Similar to the reduction of NQO1 promoter activity by siRNA 
against Nrf2, CO-induced NQO1 promoter activities were ab-
rogated by PERK siRNA suggesting that induction of NQO1 
promoter  activity  by  CORM-2  is  mediated  via  a  PERK 
pathway. Thus, our data suggest that NQO1 expression is in-
duced  by  CO  through  PERK-Nrf2  pathway. 
DISCUSSION
CO has shown the impact as a potential therapeutic molecule. 
There is an abundance of preclinical evidence in animal mod-
els of cardiovascular disease, inflammatory disorders and or-
gan transplantation showing the beneficial effects of CO, ad-
ministered  as  a  gas  or  as  a  CORM-2  (28).  NQO1  is  highly 
inducible, and its induction protected animals and their cells 
against the toxic and oxidative stress. Here we show for the 
first  time  that  CO  can  induce  NQO1  gene  transcription  in 
Nrf2-dependent  pathway,  corroborating  our  previous  report 
(22) that CO can up-regulate Nrf2-mediated HO-1 expression 
in liver cells. Nrf2 is responsible for mediating binding to the 
antioxidant responsible element (ARE) (20,29). AREs contain-
ing  12-O-tetradecanoylphorbol-13-acetate  response  element 
(TRE) (perfect AP1) elements has been reported to mediate 
high basal transcription of the human NQO1 and its induction 
in  response  to  various  stimuli  such  as  polyphenol,  xeno-
biotics,  and  oxidative  stress  (30,31). 
    In this study, we hypothesized that CO, a reaction product 
o f  t h e  c y t o p r o t e c t i v e  h e m e  o x y g e n a s e  ( H O ) - 1 ,  u p - r e g u l a t e s 
the inducible NQO1 gene expression by enhancing the Nrf2 
signaling pathway. To address this hypothesis, we first con-
firmed that CO induced NQO1 mRNA expression (Fig 1). And 
also, CORM-2 was capable of causing a significant induction 
of NQO1 at the mRNA and protein levels in HepG2 cells in 
dose-dependent  manner. 
    Furthermore, we cloned a 618-bp NQO1 promoter (pGL3/ 
NQO1p-501) that ranges from −501 to ＋117 relative to the 
transcriptional start site. When the cells were treated with on-CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
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ly CORM-2 or CO gas, NQO1 gene expression and its pro-
moter activity were significantly induced (Fig. 2 and 4). It is 
possible that CO-mediated transcription factor can bind to this 
region of NQO1 promoter. It has been shown that NQO1 pro-
moter contains antioxidant response element (ARE), a basal 
element, and AP-2 element (32). Because ARE is essentially 
required for expression and coordinated induction of NQO1, 
we measured promoter activity using pGL3/NQO1p-ARE con-
struct containing only ARE. Additionally, it was reported that 
ARE-dependent  transcriptional  activation of  the NQO1 gene 
requires the Nrf2 activation, which could consequently bind 
to  ARE  and  subsequently  activated  NQO1  transcription  (33, 
34). As shown in Fig 5, overexpression of Nrf2 resulted in 
an  induction  of  pGL3/NQO1p-ARE  promoter  activation  and 
Nrf2-mediated  NQO1  transcriptional  induction  was  sig-
nificantly enhanced by CO. In addition, knockdown of Nrf2 
and PERK resulted in a reduction of NQO1 promoter activity. 
These results indicate a possibility that NQO1 expression is 
induced  by  CO  activated  PERK-Nrf2  axis.
    CoPP is well-known to induce HO-1. Curcumin was also 
reported to increase HO-1 expression via Nrf2 to protect oxi-
dative  stress  (26).  We  demonstrated  that  HO-1  induced  by 
CoPP or curcumin would significantly increase the expression 
o f  N Q O 1 .  T h e s e  s t u d i e s  s h o w  a  p o s s i b i l i t y  t h a t  N Q O 1  e x -
pression is induced by endogenous CO generated by CoPP- 
or  curcumin-induced  HO-1.
    Several studies reported that NQO1 has various physio-
logical  functions.  For  example,  NQO1  affects  the  TNF- 
mediated  pathway  to  apoptosis  (35).  Furthermore,  etha-
nol-mediated up-regulation of HO-1 and NQO1 in THP-1 
cells led to significant decrease of inflammatory cytokines 
production,  such  as  TNF-α and  IL-1β (36).  NQO1  has 
protective  effect  against  the  development  of  Alzheimer’s 
disease (37) as well as binds to p53 and inhibits p53 deg-
radation in an ubiquitin-independent pathway via the 20S 
proteasome (11). Especially, CO gas and CORM exhibit a 
wide  range  of  biological  effects  that  encompass  inflam-
mation, apoptosis and cellular proliferation (38-40). There-
fore, we have investigated the effects of CO on the various 
physiological  functions  of  NQO1. 
    Consequently,  we  found  that  CO-induced  Nrf2  activation 
leads to up-regulation of NQO1. Because CO has a beneficial 
effect in animal model of disease, regulation of CO-mediated 
NQO1 expression through Nrf2 activation may be beneficial 
in  preventing  disease  caused  by  various  stimuli. 
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